Laboratorio Reig Jofre, S.A.

MCE RJF.MC

Laboratorio Reig Jofre, S.A. Debt to Equity Ratio for the year ending December 31, 2023: 0.26

Laboratorio Reig Jofre, S.A. Debt to Equity Ratio is 0.26 for the year ending December 31, 2023, a -16.81% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Laboratorio Reig Jofre, S.A. Debt to Equity Ratio for the year ending December 31, 2022 was 0.31, a -11.94% change year over year.
  • Laboratorio Reig Jofre, S.A. Debt to Equity Ratio for the year ending December 31, 2021 was 0.36, a 15.63% change year over year.
  • Laboratorio Reig Jofre, S.A. Debt to Equity Ratio for the year ending December 31, 2020 was 0.31, a -2.71% change year over year.
  • Laboratorio Reig Jofre, S.A. Debt to Equity Ratio for the year ending December 31, 2019 was 0.32, a 81.30% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
MCE: RJF.MC

Laboratorio Reig Jofre, S.A.

CEO Mr. Ignasi Biosca Reig
IPO Date Nov. 29, 2002
Location Spain
Headquarters Gran Capita, 10
Employees 1,331
Sector Healthcare
Industries
Description

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand. The company also provides CDMO and CMO services. It sells its products directly in 7 countries and through business partners in approximately 70 countries. The company was founded in 1929 and is based in Sant Joan Despí, Spain. Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.

Similar companies

PHM.MC

Pharma Mar, S.A.

USD 95.61

0.58%

ROVI.MC

Laboratorios Farmaceuticos Rovi, S.A.

USD 68.35

0.94%

FAE.MC

Faes Farma, S.A.

USD 3.71

0.53%

ALM.MC

Almirall, S.A.

USD 9.63

-2.28%

ORY.MC

Oryzon Genomics S.A.

USD 1.52

0.94%

StockViz Staff

February 7, 2025

Any question? Send us an email